PROGALIT
Progalit is a medical technology company specializing in urological disease treatment, particularly kidney stones. Their PROGALIT technology offers a non-invasive, AI-driven clinical decision support system for personalized prevention and treatment of kidney stones. The platform analyzes patient health data, including urine pH, diet, and medical history, to create tailored treatment plans and continuously monitor patient conditions, adjusting medication dosages as needed. This approach aims to enhance patient care, improve clinical outcomes, reduce the need for invasive procedures, and streamline clinical workflows by leveraging automation and data-driven insights. The company collaborates with European foundations, venture capital firms, and medical institutions to advance its solutions in the healthcare market.
PROGALIT
Progalit is a medical technology company specializing in urological disease treatment, particularly kidney stones. Their PROGALIT technology offers a non-invasive, AI-driven clinical decision support system for personalized prevention and treatment of kidney stones. The platform analyzes patient health data, including urine pH, diet, and medical history, to create tailored treatment plans and continuously monitor patient conditions, adjusting medication dosages as needed. This approach aims to enhance patient care, improve clinical outcomes, reduce the need for invasive procedures, and streamline clinical workflows by leveraging automation and data-driven insights. The company collaborates with European foundations, venture capital firms, and medical institutions to advance its solutions in the healthcare market.
TL;DR
Sector: Medtech / healthtech (kidney stone treatment)
Founded: 2023
HQ: Ukraine (Poltava / Kyiv references)
Product: AI-driven clinical decision support platform for personalized, non-invasive kidney stone prevention and management
Funding (reported): Grant and pre-seed rounds; reported total ≈ $70,000
Company Overview
Problem Domain
Urological disease management, specifically prevention and conservative treatment of uric acid kidney stones
Founded
2023
Industry
Medical technology / Healthtech
Funding Track Record
Investor Signal
“Seeds of Bravery listed as a recurring funder/lead on grant rounds”